
PART I - FINANCIAL INFORMATION Financial Statements The company's financial statements reveal a challenging position with decreased equity, a significant net loss, and substantial doubt about its ability to continue as a going concern Condensed Consolidated Balance Sheet Highlights (Unaudited) | Balance Sheet Item | Sep 30, 2024 | Dec 31, 2023 | | :--- | :--- | :--- | | Total Current Assets | $13,118,756 | $12,510,477 | | Total Assets | $41,910,553 | $42,629,996 | | Total Current Liabilities | $22,056,871 | $19,185,697 | | Total Liabilities | $26,403,799 | $23,189,784 | | Total Stockholders' Equity | $15,506,754 | $19,440,212 | Q3 2024 vs Q3 2023 Performance (Three Months Ended Sep 30) | Metric | Q3 2024 | Q3 2023 | | :--- | :--- | :--- | | Net Revenues | $1,812,690 | $3,522,666 | | Gross Profit | $116,075 | $132,761 | | Operating Loss | $(1,095,400) | $(1,340,830) | | Net Loss | $(1,185,409) | $(1,279,126) | Nine Months 2024 vs 2023 Performance (Nine Months Ended Sep 30) | Metric | Nine Months 2024 | Nine Months 2023 | | :--- | :--- | :--- | | Net Revenues | $5,288,668 | $15,443,644 | | Gross Profit | $546,185 | $471,572 | | Operating Loss | $(3,244,102) | $(3,696,529) | | Net Loss | $(3,986,907) | $(14,764,145) | | Loss per Share (Continuing Ops) | $(0.60) | $(2.05) | Cash Flow Summary (Nine Months Ended Sep 30) | Cash Flow Activity | 2024 | 2023 | | :--- | :--- | :--- | | Net cash provided by (used in) operating activities | $48,461 | $(4,240,629) | | Net cash (used in) provided by investing activities | $(20,317) | $2,699,069 | | Net cash (used in) provided by financing activities | $(104,628) | $1,527,688 | | Net (decrease) in cash | $(76,484) | $(13,872) | - The company's management has identified conditions that raise substantial doubt about its ability to continue as a going concern, citing a net loss of $4.3 million from continuing operations, an accumulated deficit of $144.7 million, and a working capital deficit of $8.9 million as of September 30, 202448156 - On May 31, 2024, the company effected a reverse stock split where every ten shares of common stock were converted into one new share; all prior period share and per-share data have been adjusted to reflect this split20118 - The company consolidates Jilin Chuangyuan Chemical Co, Ltd as a Variable Interest Entity (VIE), which generated revenues of $79,000 and a net loss of $1.44 million for the nine months ended September 30, 20248993 - As of September 30, 2024, the company had significant related-party balances, including $3.1 million due from related parties and $7.7 million due to related parties105106108 - For the nine months ended September 30, 2024, the company had significant customer and supplier concentration, with Customer A accounting for 28% of revenues and Supplier E accounting for 24% of purchases130132 Management's Discussion and Analysis (MD&A) Management attributes a 66% revenue decline to stagnant sales, notes strained liquidity with an $8.9 million working capital deficit, and reiterates going concern risk Results of Operations Comparison (Nine Months Ended Sep 30) | (In Thousands of USD) | 2024 | 2023 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Net revenues | 5,289 | 15,444 | (10,155) | (66) | | Gross profit | 547 | 472 | 75 | 16 | | Selling and marketing expenses | 105 | 721 | (616) | (85) | | Operating loss | (3,243) | (3,696) | 453 | (12) | | Net loss | (3,986) | (14,764) | 10,778 | (73) | Key Liquidity Metrics | Metric | Sep 30, 2024 | Dec 31, 2023 | | :--- | :--- | :--- | | Cash and cash equivalents | $227,492 | $270,317 | | Working Capital Deficit | $8,938,115 | N/A | | Debt to Assets Ratio | 63.0% | 54.4% | - The decrease in nine-month revenue was attributed to stagnant sales of high-grade synthetic fuel products and a decline in food product sales149 - The increase in nine-month gross profit was primarily due to a significant increase in high-margin advertising revenue from the Fast Approach branch151 - The company's primary sources of financing have been cash from operations and private placements, and it may need to continue relying on these sources or reduce expenditures154157 Quantitative and Qualitative Disclosures About Market Risk The company is a smaller reporting company and is therefore not required to provide these disclosures - As a smaller reporting company defined in Rule 12b-2, the company is not required to provide the information for this item165 Controls and Procedures Management concluded disclosure controls were ineffective due to a material weakness in internal control over financial reporting - Management concluded that disclosure controls and procedures were not effective as of September 30, 2024167 - A material weakness was identified in internal control over financial reporting relating to ineffective review and approval procedures over journal entries and financial statement preparation169 - The control failure resulted in errors not being timely identified, such as the overstatement of income from the discontinued operation related to the disposal of Allinyson Ltd169 - Remediation plans include enhancing the system of evaluating complex accounting standards, providing better access to accounting literature, and increasing communication among personnel170 PART II - OTHER INFORMATION Legal Proceedings The company is involved in a breach of contract lawsuit with a former employee seeking over $600,000 in damages - On July 27, 2023, former employee Daqi Cui filed a complaint against the Company for breach of employment contract, seeking $609,145.05 in damages171 - The Company filed a motion on November 6, 2023, to move the case to the United States District Courthouse and have it dismissed with prejudice171 Risk Factors No material changes to previously disclosed risk factors have occurred since the April 2023 filing - As of the date of this report, there have been no material changes to the risk factors disclosed in the Company's registration statement Form S3/A filed on April 18, 2023172 Unregistered Sales of Equity Securities and Use of Proceeds This item is not applicable for the reporting period - Not applicable173 Other Information There is no other information to report for this period - None173 Exhibits Filed exhibits include officer certifications required by the Sarbanes-Oxley Act and Inline XBRL data files - Exhibits filed with the report include CEO and CFO certifications pursuant to Sarbanes-Oxley Act Sections 302 and 906174 - Inline XBRL documents (Instance, Schema, Calculation, Definition, Label, Presentation) are also filed as exhibits174 Signatures - The report was duly signed on November 14, 2024, by Bin Zhou, Chief Executive Officer, and Lili Hu, Chief Financial Officer175176